Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05756647 · ClinicalTrials.gov registry record · Phase 2

Mandibular Advancement vs Home Treatment for Primary Snoring

A Phase 2 study, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 2
Development phase
100
Enrollment target

NCT05756647 is a Phase 2 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05756647, a Phase 2 study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 2
Development phase
100 participants
Enrollment target

Study Summary

This is a randomized controlled trial for non-apneic snorers. The primary goal of the study is to evaluate the efficacy of a mandibular advancement device (MAD) vs conservative treatment for adults with non-apneic snoring as measured by the partners report of response to treatment (CGI-I). The secondary goal is to evaluate the effectiveness of treatment of snoring on the Epworth Sleepiness Scale (ESS), a modified Symptoms of Nocturnal Obstruction and Related Events (SNORE-25) questionnaire, the Pittsburgh Sleep Quality Index (PSQI), and the Clinical Global Impression of Severity Scale (CGI-S)

Interventions

  • DEVICE Interventional Arm
  • COMBINATION_PRODUCT Conservative treatment Arm

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-11-07
Est. Completion 2023-07-03
Phase Phase 2

What the Registry Record Tells You About NCT05756647

The ClinicalTrials.gov registry entry for NCT05756647 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Interventional Arm is the first listed.

NCT05756647 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05756647 about?

NCT05756647 is a clinical study titled "Mandibular Advancement vs Home Treatment for Primary Snoring". This is a randomized controlled trial for non-apneic snorers. The primary goal of the study is to evaluate the efficacy of a mandibular advancement device (MAD) vs conservative treatment for adults with non-apneic snoring as measured by the partners report of response to treatment (CGI-I). The secon...

What is the current status of trial NCT05756647?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2022-11-07. Estimated completion is 2023-07-03.

What interventions are being tested in trial NCT05756647?

The interventions under investigation include: Interventional Arm (DEVICE), Conservative treatment Arm (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT05756647?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.